SrinivasVourgantiMD

PubMed

• 109 citations
  Defining Early-Onset Kidney Cancer: Implications for Germline and Somatic Mutation Testing and Clinical Management
  Brian Shuch, Srinivas Vourganti, Christopher J. Ricketts, Lindsay Middleton, James Peterson
  Journal of Clinical Oncology. 2014-02-10
• 13 citations
  Novel non-MRI imaging techniques for primary diagnosis of prostate cancer: micro-ultrasound, contrast-enhanced ultrasound, elastography, multiparametric ultrasound, an...
  Francesco Ditonno, Antonio Franco, Celeste Manfredi, Alessandro Veccia, Massimo Valerio
  Prostate Cancer and Prostatic Diseases. 2024-03-01
• 27 citations
  Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis.
  Abhinav Sidana, Matthew J. Watson, Arvin K. George, Ardeshir R. Rastinehad, Srinivas Vourganti
  Urologic Oncology. 2018-05-10

Journal Articles

• Chromophobe Renal Cell Carcinoma Is the Most Common Nonclear Renal Cell Carcinoma in Young Women: Results from the SEER Database  
  Daugherty M, Blakely S, Shapiro O, Vourganti S, Mollapour M, Bratslavsky G, Journal of Urology, 1/1/2016
• Lack of Impact of Robotic Assisted Laparoscopic Radical Prostatectomy on Intraoperative Levels of Prostate Cancer Circulating Tumor Cells  
  Kauffman EC, Lee MJ, Alarcon SV, Lee S, Hoang AN, Walton Diaz A, Chelluri R, Vourganti S, Trepel JB, Pinto PA, Journal of Urology, 1/1/2016
• Pannus Is the New Prepuce? Penile Cancer in a Buried Phallus  
  Manwaring J, Vourganti S, Nikolavsky D, Valente AL, Byler T, Case Reports in Urology, 1/1/2015
• Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes  
  Martucci VL, Lorenzo ZG, Weintraub M, Del Rivero J, Ling A, Merino M, Siddiqui M, Shuch B, Vourganti S, Linehan WM, Agarwal PK, Pacak K, Urologic Oncology, 1/1/2015
• Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without pr...  
  Rais-Bahrami S, Siddiqui MM, Vourganti S, Turkbey B, Rastinehad AR, Stamatakis L, Truong H, Walton-Diaz A, Hoang AN, Nix JW, Merino MJ, Wood BJ, Simon RM, Choyke PL, P..., British Journal of Urology International, 1/1/2015
• Defining the radiobiology of prostate cancer progression: An important question in translational prostate cancer research  
  Vourganti S, Donaldson J, Johnson L, Turkbey B, Bratslavsky G, Kotula L, Experimental Biology and Medicine, 1/30/2014
• Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up  
  Rais-Bahrami S, Turkbey B, Rastinehad AR, Walton-Diaz A, Hoang AN, Siddiqui MM, Stamatakis L, Truong H, Nix JW, Vourganti S, Grant KB, Merino MJ, Choyke PL, Pinto PA, Diagnostic and Interventional Radiology, 1/1/2014
• Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session  
  Hong CW, Walton-Diaz A, Rais-Bahrami S, Hoang AN, Turkbey B, Stamatakis L, Xu S, Amalou H, Siddiqui MM, Nix JW, Vourganti S, Merino MJ, Choyke PL, Wood BJ, Pinto PA, Diagnostic and Interventional Radiology, 1/1/2014
• Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management  
  Shuch B, Vourganti S, Ricketts CJ, Middleton L, Peterson J, Merino MJ, Metwalli AR, Srinivasan R, Linehan WM, Journal of Clinical Oncology, 1/1/2014
• Adverse health outcomes associated with surgical management of the small renal mass  
  Shuch B, Hanley JM, Lai JC, Vourganti S, Setodji CM, Dick AW, Chow WH, Saigal CS, Journal of Urology, 1/1/2014
• Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? - Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) Database  
  Vourganti S, Harbin A, Singer EA, Shuch B, Metwalli AR, Agarwal PK, Journal of Cancer, 1/6/2013
• MRI characterization of the dynamic effects of 5alpha-reductase inhibitors on prostate zonal volumes  
  Truong H, Logan J, Turkbey B, Siddiqui MM, Rais-Bahrami S, Hoang AN, Pusateri C, Shuch B, Walton-Diaz A, Vourganti S, Nix J, Stamatakis L, Harris C, Chua C, Choyke PL,..., Canadian Journal of Urology, 1/1/2013
• Estrogen receptor-Beta expression and pharmacological targeting in bladder cancer  
  Kauffman EC, Robinson BD, Downes M, Marcinkiewicz K, Vourganti S, Scherr DS, Gudas LJ, Mongan NP, Oncology Reports, 1/1/2013
• Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates?  
  Walton Diaz A, Hoang AN, Turkbey B, Hong CW, Truong H, Sterling T,Rais-Bahrami S, Siddiqui MM, Stamatakis L, Vourganti S, Nix J, Logan J, Harris C,Weintraub M, Chua C,..., Journal of Urology, 1/1/2013
• Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy Significantly Upgrades Prostate Cancer Versus Systematic 12-core Transrectal Ultrasound Biopsy  
  Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, HoangAN, Walton-Diaz A, Shuch B, Weintraub M, Kruecker J, Amalou H, Turkbey B, Merino MJ, Choy..., European Urology, 1/1/2013
• Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer  
  Rais-Bahrami S, Siddiqui MM, Turkbey B, Stamatakis L, Logan J, Hoang AN,Walton-Diaz A, Vourganti S, Truong H, Kruecker J, Merino MJ, Wood BJ, Choyke PL, Pinto PA, Journal of Urology, 1/1/2013
• the Epidermal Growth Factor Receptor in Bladder Cancer  
  Weintraub MD, Vourganti S, Li Q, Apolo AB, Metwalli AR, Agarwal PK, Journal of Carcinogenesis & Mutagenes, 1/1/2013
• Multiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detects Prostate Cancer in Patients with Prior Negative Transrectal Ultrasound Biopsies  
  Vourganti S, Rastinehad A, Yerram N, Nix J, Volkin D, Hoang A, Turkbey B, Gupta GN, Krueker J, Linehan WM, Choyke PL, Wood BJ, Pinto PA, Journal of Urology, 1/17/2012
• Outcomes of Patients with Surgically Treated Bilateral Renal Masses and a Minimum of 10 Years of Followup  
  Singer EA, Vourganti S, Lin KY, Gupta GN, Pinto PA, Rastinehad AR, Linehan WM, Bratslavsky G, Journal of Urology, 1/17/2012
• Age related changes in prostate zonal volume as measured by high resolution prostate MRI: a cross sectional study in over 500 patients  
  Turkbey B, Huang R, Vourganti S, Trivedi H, Bernardo M, Yan P, Benjamin C, Pinto PA, Choyke PL, British Journal of Urology International, 1/14/2012
• Image guidance in the focal treatment of prostate cancer  
  Hoang AN, Volkin D, Yerram NK, Vourganti S, Nix J, Linehan WM, Wood B, Pinto PA, Current Opinion in Urology, 1/1/2012
• Hinman’s Atlas of Urologic Surgery  
  Vourganti S, Ponsky LE, 1/1/2012
• Hinman’s Atlas of Urologic Surgery  
  Vourganti S, Ponsky LE, 1/1/2012
• Hinman’s Atlas of Urologic Surgery  
  Vourganti S, Ponsky LE, 1/1/2012
• Targeting the mTOR pathway in Chromophobe Kidney Cancer  
  Shuch B, Vourganti S, Friend JC, Zehngebot LM, Linehan WM, Srinivasan R, Journal of Cancer, 1/1/2012
• Join now to see all

Books/Book Chapters

• Surgical Techniques for Prostate Cancer 
  Chapter: Magnetic Resonance Imaging in Prostate Cancer Diagnosis 
  Page 15 - 20Vourganti S, Wojtowycz ASpringer2014

Abstracts/Posters

• Multi-institutional Assessment of Multiparametric MRI and Fusion Biopsy of the Prostate in a Biopsy-Naïve Population
  Vourganti S, American Urologic Association National Meeting, San Diego, CA, 1/1/2016
• MRI Fusion Prostate Biopsy Outperforms 12-Core Systeatic Prostate Biopsy in Patients With Prior Negative Biopsy History: A Multi-institutional Analysis
  Vourganti S, American Urologic Association National Meeting, San Diego, CA, 1/1/2016
• High rates of metastatic disease in prostate cancer among BRCA2 mutation carriers: implications for screening
  Vourganti S, American Urologic Association National Meeting, San Diego, CA, 1/1/2016
• Clinical Features Of Prostate Cancer In Confirmed Brca2+ Mutation Carriers
  Vourganti S, American Urologic Association – Northeast Section Annual Meeting, Quebec City, Quebec, 1/1/2015
• Size Does Matter: Improving The Diagnostic Value Of Prostate Multiparametric MRI With The Consideration Of Lesion Volumes
  Vourganti S, American Urologic Association – Northeast Section Annual Meeting, Quebec City, Quebec, 1/1/2015
• Can We Afford Prostate MRI, and Is it Worth it? – A Decision Analysis Comparing Cost Effectiveness of Systematic Transrectal Ultrasound Guided Biopsy and MRI–Ultrasoun...
  Vourganti S, American Urologic Association – Northeast Section Annual Meeting, Amelia Island, FL, 1/1/2014
• Stromal testicular tumors exhibit worse cancer-specific survival compared to germ cell testicular tumors in all stage categories
  Vourganti S, American Urologic Association National Meeting, Orlando, FL, 1/1/2014
• Verification of Traditional Extended Systematic 12-Core TRUS Prostate Biopsy using Electromagnetic Tracking
  Vourganti S, American Urologic Association National Meeting, San Diego, CA, 1/1/2013
• Multiparametric MRI and Ultrasound Fusion Biopsy Detects Prostate Cancer in Patients With Prior Negative Biopsies
  Vourganti S, American Urologic Association National Meeting, Atlanta, GA, 1/1/2012
• Low Suspicion Lesions On Multiparametric Magnetic Resonance Imaging Do Not Signify High Risk Cancer
  Vourganti S, American Urologic Association National Meeting, Atlanta, GA, 1/1/2012
• Verification of Traditional Extended Systematic 12-Core TRUS Prostate Biopsy using Electromagnetic Tracking
  Vourganti S, Society of Urologic Oncology National Meeting, Bethesda, MD, 1/1/2012
• Low Grade Micropapillary Urothelial Carcinoma – Does It Exist? - A SEER Analysis of Management and Outcomes
  Vourganti S, Society of Urologic Oncology National Meeting, Bethesda, MD, 1/1/2012
• Comparison of Partial Nephrectomy for Tumors Greater Than 7 cm to Radical Nephrectomy and Effect on Overall Survival
  Vourganti S, American Society of Clinical Oncology – Genitourinary Cancer Meeting, Orlando, FL, 1/1/2011
• Role of heat shock protein 90 inhibition with 17-(allylamino)-17 (demethoxygeldenamycin) in muscle-invasive bladder cancer cells
  Vourganti S, American Society of Clinical Oncology – Genitourinary Cancer Meeting, Orlando, FL, 1/1/2011
• PSA/SIA: Progress Report For A New Assay For Prostate Cancer
  Vourganti S, American Urologic Association – North Central Section Annual Meeting, Chicago, IL, 1/1/2010
• Use of 5-Alpha Reductase Inhibitors In Treatment of Biochemical Failure Following Radical Prostatectomy Following Radical Prostatectomy in Sexually Active Patients
  Vourganti S, American Urologic Association – North Central Section Annual Meeting, Chicago, IL, 1/1/2010
• Metastatic Prostate Cancer as the Initial Diagnosis in the PSA Era
  Vourganti S, American Urologic Association – North Central Section Annual Meeting, Chicago, IL, 1/1/2010
• Prostate Specific Antigen/Solvent Interaction Analysis (PSA/SIA): A New Assay For Improved Prostate Cancer (CaP) Diagnosis
  Vourganti S, American Urologic Association National Meeting; American Society of Clinical Oncology National Meeting, Orlando, FL, 1/1/2009
• Is a positive surgical margin important following nephron sparing surgery?
  Vourganti S, Society of Urologic Oncology National Meeting, Bethesda, MD, 1/1/2008
• Treatment of Epstein-Barr Virus Transformed B-Cell Lines with the Histone Deacetylase Inhibitor Depsipeptide (FR901228) Results in the Induction of a Viral Thymidine K...
  Vourganti S, American College of Physicians Annual Meeting, Philadelphia, PA
• Join now to see all

Lectures

• Debate: Ultrasound-MRI Fusion Guided Biopsy vs. Transperineal Approach 
  Buenos Aires, Argentina - 1/1/2016
• MR/US Fusion-Guided Prostate Biopsy: Beginner and Advanced Techniques 
  Chicago, IL - 1/1/2016
• The Expanding Role of Partial Prostate Gland Ablation (Focal Therapy) in the Era of Imaging Based Prostate Cancer Management 
  Chattanooga, TN - 1/1/2016
• Magnetic Resonance Imaging in Prostate Cancer Diagnosis 
  Multiple locations, 2014, 2015, 2016 - 1/1/2016
• Rationale of MRI/US Fusion Biopsy in Active Surveillance of Prostate Cancer 
  Linthicum, MD - 1/1/2016
• Troubleshooting common problems in Uronav Fusion prostate biopsy 
  Linthicum, MD - 1/1/2016
• Master Class: Prostate Cancer Biopsies – Current Concepts 
  Buenos Aires, Argentina - 1/1/2016
• Latest Advances in Prostate Fusion Biopsy 
  New Orleans, LA - 1/1/2015
• Cost of Prostate MRI-US Fusion– A Decision Analysis comparing cost effectiveness of Systematic Transrectal Ultrasound Guided Biopsy and MRI-Ultrasound Fusion Prostate ... 
  New Orleans, LA - 1/1/2015
• The Evolving Role of Magnetic Resonance Imaging in Prostate Cancer Diagnosis 
  Burlington, VT - 1/1/2014
• MRI/Ultrasound Image Fusion in the Diagnosis & Treatment of Prostate Cancer 
  Rochester, NY - 1/1/2014
• Rationale of Focal Therapy of Prostate Cancer 
  Saratoga Springs, NY - 1/1/2013
• Outcomes of Patients with Surgically Treated Bilateral Renal Masses and a Minimum of 10 Years of Follow-up: The NCI Experience 
  Washington, DC - 1/1/2011
• Focal Cryoablation for Low Risk Prostate Cancer: Preliminary Observations 
  Chicago, IL - 1/1/2010
• Patient Reported Outcomes With Vacuum Erection Device For Erectile Dysfunction 
  Scottsdale, AZ - 1/1/2009
• Abnormal Bone Mineral Density in Men with Symptomatic Hypogonadism 
  Orlando, FL - 1/1/2008
• The Impact of Primary Tumor Anatomic Location on Aggressive Disease Behavior of Localized Renal Cell Carcinoma 
  Sandusky, OH - 1/1/2008
• Join now to see all

Other

• Hydronephrosis and Hydroureter 
  Vourganti S, Maniam P, Resnick MI, eMedicine
  http://www.emedicine.com/ED/topic1055.htm
  1/1/2008